Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
-0.25%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$26B
AUM Growth
-$840M
(-3.1%)
Cap. Flow
+$43M
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
41.42%
Holding
108
New
25
Increased
27
Reduced
18
Closed
26
Top Buys
| 1 |
Adobe
ADBE
|
+$952M |
| 2 |
Netflix
NFLX
|
+$630M |
| 3 |
JPMorgan Chase
JPM
|
+$609M |
| 4 |
DoorDash
DASH
|
+$602M |
| 5 |
McDonald's
MCD
|
+$478M |
Top Sells
| 1 |
Visa
V
|
+$1.77B |
| 2 |
Advanced Micro Devices
AMD
|
+$713M |
| 3 |
Danaher
DHR
|
+$709M |
| 4 |
GE Aerospace
GE
|
+$480M |
| 5 |
UnitedHealth
UNH
|
+$468M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.32% |
| 3 | Financials | 15.71% |
| 4 | Consumer Discretionary | 15.6% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sherwin-Williams
SHW
$89.8B
| $122M | 0.47% |
+407,786
| New | +$122M |
|
52
Apollo Global Management
APO
$79B
| $115M | 0.44% |
+971,224
| New | +$115M |
|
53
Adaptive Biotechnologies
ADPT
$1.92B
| $109M | 0.42% |
29,993,708
| – | – |
|
54
Salesforce
CRM
$231B
| $104M | 0.4% |
+405,135
| New | +$104M |
|
55
Standard BioTools
LAB
$493M
| $104M | 0.4% |
58,651,170
| – | – |
|
56
Oscar Health
OSCR
$5B
| $93.8M | 0.36% |
5,928,038
+1,196,036
| +25% | +$18.9M |
|
57
Procore
PCOR
$10.5B
| $91.1M | 0.35% |
1,374,580
+383,351
| +39% | +$25.4M |
|
58
Allstate
ALL
$52.8B
| $87M | 0.33% |
+545,182
| New | +$87M |
|
59
McKesson
MCK
$88.5B
| $83M | 0.32% |
142,169
-448,411
| -76% | -$262M |
|
60
FIVE9
FIVN
$2B
| $76.5M | 0.29% |
1,734,414
-1,717,724
| -50% | -$75.8M |
|
61
NRG Energy
NRG
$31.9B
| $73.5M | 0.28% |
+943,457
| New | +$73.5M |
|
62
Viking Therapeutics
VKTX
$2.79B
| $71.8M | 0.28% |
1,354,450
+259,510
| +24% | +$13.8M |
|
63
Carvana
CVNA
$50B
| $71.3M | 0.27% |
+553,621
| New | +$71.3M |
|
64
Insmed
INSM
$30.8B
| $69.4M | 0.27% |
+1,035,970
| New | +$69.4M |
|
65
Pharvaris
PHVS
$1.49B
| $68.7M | 0.26% |
3,653,310
| – | – |
|
66
4D Molecular Therapeutics
FDMT
$318M
| $61.6M | 0.24% |
2,934,914
| – | – |
|
67
Immunovant
IMVT
$2.82B
| $61.3M | 0.24% |
2,320,902
+511,730
| +28% | +$13.5M |
|
68
Vertiv
VRT
$51.5B
| $59.7M | 0.23% |
689,687
-328,307
| -32% | -$28.4M |
|
69
KKR & Co
KKR
$128B
| $57.4M | 0.22% |
545,092
-526,074
| -49% | -$55.4M |
|
70
Ginkgo Bioworks
DNA
$593M
| $47.8M | 0.18% |
3,577,128
| – | – |
|
|
LBPH
71
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $44.8M | 0.17% |
1,658,962
+677,634
| +69% | +$18.3M |
|
72
LPL Financial
LPLA
$28.1B
| $36.3M | 0.14% |
+130,000
| New | +$36.3M |
|
73
Zai Lab
ZLAB
$3.65B
| $35.3M | 0.14% |
2,037,374
-10,755
| -0.5% | -$186K |
|
74
Day One Biopharmaceuticals
DAWN
$729M
| $35.3M | 0.14% |
2,558,563
| – | – |
|
75
Oric Pharmaceuticals
ORIC
$1.05B
| $28.3M | 0.11% |
4,000,000
| – | – |
|